631 reports of this reaction
1.8% of all NOREPINEPHRINE BITARTRATE reports
#12 most reported adverse reaction
SEPTIC SHOCK is the #12 most commonly reported adverse reaction for NOREPINEPHRINE BITARTRATE, manufactured by Deseret Biologicals, Inc.. There are 631 FDA adverse event reports linking NOREPINEPHRINE BITARTRATE to SEPTIC SHOCK. This represents approximately 1.8% of all 35,563 adverse event reports for this drug.
Patients taking NOREPINEPHRINE BITARTRATE who experience septic shock should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SEPTIC SHOCK is a less commonly reported adverse event for NOREPINEPHRINE BITARTRATE, but still significant enough to appear in the safety profile.
In addition to septic shock, the following adverse reactions have been reported for NOREPINEPHRINE BITARTRATE:
The following drugs have also been linked to septic shock in FDA adverse event reports:
SEPTIC SHOCK has been reported as an adverse event in 631 FDA reports for NOREPINEPHRINE BITARTRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SEPTIC SHOCK accounts for approximately 1.8% of all adverse event reports for NOREPINEPHRINE BITARTRATE, making it a notable side effect.
If you experience septic shock while taking NOREPINEPHRINE BITARTRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.